Moreover, tumor location and ages of PC patients showed significant relevance to the expression of METTL14 (Table 1), which indicated METTL14 was closely related with tumor progression and could be utilized as a prognostic marker in pancreatic cancer. The gene discussed is METTL14; the disease is familial pancreatic carcinoma.